Mike Mensinger's most recent trade in Beta Bionics Inc. was a trade of 708 Common Stock done at an average price of $18.1 . Disclosure was reported to the exchange on June 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Beta Bionics Inc. | Mike Mensinger | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 18.15 per share. | 02 Jun 2025 | 708 | 93,005 | - | 18.1 | 12,849 | Common Stock |
| Beta Bionics Inc. | Mike Mensinger | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 17.03 per share. | 02 Jun 2025 | 306 | 93,713 | - | 17.0 | 5,211 | Common Stock |
| Beta Bionics Inc. | Mike Mensinger | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 18.69 per share. | 02 Jun 2025 | 101 | 92,904 | - | 18.7 | 1,888 | Common Stock |
| Beta Bionics Inc. | Mike Mensinger | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 52,000 | 52,000 | - | - | Employee Stock Option (right to buy) | |
| Beta Bionics Inc. | Mike Mensinger | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 35,000 | 94,019 | - | 0 | Common Stock | |
| Beta Bionics Inc. | Mike Mensinger | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 236,553 | 236,553 | - | - | Employee Stock Option (right to buy) | |
| Beta Bionics Inc. | Mike Mensinger | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 110,278 | 110,278 | - | - | Employee Stock Option (right to buy) | |
| Beta Bionics Inc. | Mike Mensinger | Chief Product Officer | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 31 Jan 2025 | 33,350 | 59,019 | - | 17 | 566,950 | Common Stock |
| Beta Bionics Inc. | Mike Mensinger | Chief Product Officer | 31 Jan 2025 | 15,107 | 0 | - | - | Series D Preferred Stock | ||
| Beta Bionics Inc. | Mike Mensinger | Chief Product Officer | 31 Jan 2025 | 15,107 | 15,107 | - | - | Common Stock | ||
| Beta Bionics Inc. | Mike Mensinger | Chief Product Officer | 31 Jan 2025 | 10,575 | 0 | - | - | Class B Common Stock Warrant (right to buy) | ||
| Beta Bionics Inc. | Mike Mensinger | Chief Product Officer | 31 Jan 2025 | 10,575 | 10,575 | - | - | Class B Common Stock Warrant (right to buy) | ||
| Beta Bionics Inc. | Mike Mensinger | Chief Product Officer | 31 Jan 2025 | 10,575 | 25,682 | - | 0.0 | 212 | Common Stock | |
| Beta Bionics Inc. | Mike Mensinger | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 17.00 per share. | 31 Jan 2025 | 13 | 25,669 | - | 17 | 221 | Common Stock |
| Beta Bionics Inc. | Mike Mensinger | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2025 | 110,278 | 110,278 | - | - | Employee Stock Option (right to buy) |